Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice

In recent years oral mucosal injury has been increasingly recognized as an important toxicity associated with mammalian target of rapamycin (mTOR) inhibitors, including in patients with breast cancer who are receiving everolimus. This review addresses the state‐of‐the‐science regarding mTOR inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Douglas E., O'Shaughnessy, Joyce A., Rugo, Hope S., Elad, Sharon, Schubert, Mark M., Viet, Chi T., Campbell‐Baird, Cynthia, Hronek, Jan, Seery, Virginia, Divers, Josephine, Glaspy, John, Schmidt, Brian L., Meiller, Timothy F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971919/
https://www.ncbi.nlm.nih.gov/pubmed/27334013
http://dx.doi.org/10.1002/cam4.761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971919/
https://www.ncbi.nlm.nih.gov/pubmed/27334013
http://dx.doi.org/10.1002/cam4.761

Ejemplares similares